Eduardo Schenberg
Neuroscientist and founder/director of Instituto Phaneros
Data updated
Research Footprint
Eduardo Schenberg appears in 11 tracked papers (2013–2024), most studied alongside Ayahuasca, Ibogaine and Psilocybin, across Depressive Disorders, Substance Use Disorders (SUD) and Equity and Ethics.
Most-cited paper: Neural correlates of the LSD experience revealed by multimodal neuroimaging (875 citations).
Frequent co-authors: Draulio Silveira, Dartiu Xavier da Silveira and Luiz Tófoli.
Background & Research
Eduardo Ekman Schenberg is a Brazilian neuroscientist with training in biomedicine, psychopharmacology, and neuroscience. His work has focused on the therapeutic and subjective effects of psychedelics, including ayahuasca, ibogaine, MDMA, LSD, and psilocybin, and he founded Instituto Phaneros to advance psychedelic-assisted psychotherapy and education.
Key Impact
A leading Brazilian psychedelic researcher known for clinical and translational work on ayahuasca, ibogaine, MDMA, and ethics/policy in psychedelic medicine.
Collaboration Network
29 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Eduardo Schenberg is associated with.
Instituto Phaneros
Instituto Phaneros is a Brazilian non-profit institute focused on psychedelic-assisted psychotherapy research, education, and clinical protocol development. Its activities include professional training for participation in scientific research, supervised clinical internships in research protocols, and ongoing development of psychedelic-assisted psychotherapy protocols.
View stakeholder →University College London
academicThe Understanding Neuroplasticity Induced by Tryptamines (UNITY) Project was launched at University College London. UNITY represents the first-in-human study of psychedelics at UCL. The team utilizes techniques such as fMRI, eye-tracking and experience sampling to enhance our understanding of the neurobiological mechanisms predicting cognitive and mental health outcomes following psychedelic use, initially investigating the effects of DMT.
View stakeholder →Federal University of São Paulo (UNIFESP)
The Federal University of São Paulo (UNIFESP) is a public federal research university based in the state of São Paulo, Brazil, with multiple campuses and a strong reputation in health sciences and related programs.
View stakeholder →